Impact of catheter ablation for atrial fibrillation on cardiac disorders in patients with coexisting heart failure
Abstract Aims We sought to investigate the time course of cardiac disorders after catheter ablation for atrial fibrillation (AF) in patients with coexisting heart failure (HF) during long‐term follow‐up. Methods and results We analysed consecutive 280 patients undergoing first‐time catheter ablation...
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-02-01
|
Series: | ESC Heart Failure |
Subjects: | |
Online Access: | https://doi.org/10.1002/ehf2.13160 |
id |
doaj-0a7fd11155f24889bc493bc778ecdbec |
---|---|
record_format |
Article |
spelling |
doaj-0a7fd11155f24889bc493bc778ecdbec2021-03-31T03:15:45ZengWileyESC Heart Failure2055-58222021-02-018167067910.1002/ehf2.13160Impact of catheter ablation for atrial fibrillation on cardiac disorders in patients with coexisting heart failureTetsuma Kawaji0Satoshi Shizuta1Takanori Aizawa2Shintaro Yamagami3Masashi Kato4Takafumi Yokomatsu5Shinji Miki6Koh Ono7Takeshi Kimura8Department of Cardiology Ryorei Memorial Kyoto Hospital Kyoto JapanDepartment of Cardiovascular Medicine, Graduate School of Medicine Kyoto University 54 Shogoin Kawahara‐cho, Sakyo‐ku Kyoto 606‐8507 JapanDepartment of Cardiovascular Medicine, Graduate School of Medicine Kyoto University 54 Shogoin Kawahara‐cho, Sakyo‐ku Kyoto 606‐8507 JapanDepartment of Cardiovascular Medicine Tenri Hospital Tenri JapanDepartment of Cardiology Ryorei Memorial Kyoto Hospital Kyoto JapanDepartment of Cardiology Ryorei Memorial Kyoto Hospital Kyoto JapanDepartment of Cardiology Ryorei Memorial Kyoto Hospital Kyoto JapanDepartment of Cardiovascular Medicine, Graduate School of Medicine Kyoto University 54 Shogoin Kawahara‐cho, Sakyo‐ku Kyoto 606‐8507 JapanDepartment of Cardiovascular Medicine, Graduate School of Medicine Kyoto University 54 Shogoin Kawahara‐cho, Sakyo‐ku Kyoto 606‐8507 JapanAbstract Aims We sought to investigate the time course of cardiac disorders after catheter ablation for atrial fibrillation (AF) in patients with coexisting heart failure (HF) during long‐term follow‐up. Methods and results We analysed consecutive 280 patients undergoing first‐time catheter ablation for AF who had coexisting HF, which was defined as prior HF hospitalization, estimated right ventricular systolic pressure ≥45 mmHg, or B‐type natriuretic peptide (BNP) ≥200 pg/dL before the procedure. The primary endpoints were improvements in left ventricular ejection fraction (LVEF), E/e′, BNP, left atrial dimension (LAD), and mitral regurgitation (MR) at 1 year. The secondary endpoints were serial changes of LVEF, E/e′, BNP, LAD, and MR at 6 months, 1 year, and 5 years and cumulative incidence of HF hospitalization. During the mean follow‐up of 5.1 ± 3.0 years, 70.7% of patients were free from recurrent AF. Among patients with LVEF < 50%, E/e′ ≥ 15, BNP ≥ 200 pg/dL, LAD ≥ 40 mm, and moderate‐to‐severe MR, changes in those parameters from baseline to 1 year were 34.5 ± 9.9% to 43.2 ± 14.4% (P < 0.001), 19.7 ± 3.9 to 12.5 ± 6.6 (P < 0.001), 290 to 85 pg/dL (P < 0.001), and 100% to 37.8% (P < 0.001), respectively. The improvements in the cardiac disorders were maintained up to 5 years except for E/e′. In patients with LVEF < 40%, significant delayed improvement of LVEF beyond 1 year was observed (ΔLVEF = 10.5 ± 18.5, P = 0.001), but not in patients with LVEF of 40–49%. The cumulative incidence of HF hospitalization was 12.6% at 5 years. Baseline diastolic dysfunction was the only independent predictor for subsequent HF hospitalization. Conclusions In patients undergoing AF ablation with coexisting HF, all cardiac disorders significantly improved after the procedure, which was mostly maintained during 5 year follow‐up.https://doi.org/10.1002/ehf2.13160Atrial fibrillationCatheter ablationHeart failureSystolic dysfunctionDiastolic dysfunction |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Tetsuma Kawaji Satoshi Shizuta Takanori Aizawa Shintaro Yamagami Masashi Kato Takafumi Yokomatsu Shinji Miki Koh Ono Takeshi Kimura |
spellingShingle |
Tetsuma Kawaji Satoshi Shizuta Takanori Aizawa Shintaro Yamagami Masashi Kato Takafumi Yokomatsu Shinji Miki Koh Ono Takeshi Kimura Impact of catheter ablation for atrial fibrillation on cardiac disorders in patients with coexisting heart failure ESC Heart Failure Atrial fibrillation Catheter ablation Heart failure Systolic dysfunction Diastolic dysfunction |
author_facet |
Tetsuma Kawaji Satoshi Shizuta Takanori Aizawa Shintaro Yamagami Masashi Kato Takafumi Yokomatsu Shinji Miki Koh Ono Takeshi Kimura |
author_sort |
Tetsuma Kawaji |
title |
Impact of catheter ablation for atrial fibrillation on cardiac disorders in patients with coexisting heart failure |
title_short |
Impact of catheter ablation for atrial fibrillation on cardiac disorders in patients with coexisting heart failure |
title_full |
Impact of catheter ablation for atrial fibrillation on cardiac disorders in patients with coexisting heart failure |
title_fullStr |
Impact of catheter ablation for atrial fibrillation on cardiac disorders in patients with coexisting heart failure |
title_full_unstemmed |
Impact of catheter ablation for atrial fibrillation on cardiac disorders in patients with coexisting heart failure |
title_sort |
impact of catheter ablation for atrial fibrillation on cardiac disorders in patients with coexisting heart failure |
publisher |
Wiley |
series |
ESC Heart Failure |
issn |
2055-5822 |
publishDate |
2021-02-01 |
description |
Abstract Aims We sought to investigate the time course of cardiac disorders after catheter ablation for atrial fibrillation (AF) in patients with coexisting heart failure (HF) during long‐term follow‐up. Methods and results We analysed consecutive 280 patients undergoing first‐time catheter ablation for AF who had coexisting HF, which was defined as prior HF hospitalization, estimated right ventricular systolic pressure ≥45 mmHg, or B‐type natriuretic peptide (BNP) ≥200 pg/dL before the procedure. The primary endpoints were improvements in left ventricular ejection fraction (LVEF), E/e′, BNP, left atrial dimension (LAD), and mitral regurgitation (MR) at 1 year. The secondary endpoints were serial changes of LVEF, E/e′, BNP, LAD, and MR at 6 months, 1 year, and 5 years and cumulative incidence of HF hospitalization. During the mean follow‐up of 5.1 ± 3.0 years, 70.7% of patients were free from recurrent AF. Among patients with LVEF < 50%, E/e′ ≥ 15, BNP ≥ 200 pg/dL, LAD ≥ 40 mm, and moderate‐to‐severe MR, changes in those parameters from baseline to 1 year were 34.5 ± 9.9% to 43.2 ± 14.4% (P < 0.001), 19.7 ± 3.9 to 12.5 ± 6.6 (P < 0.001), 290 to 85 pg/dL (P < 0.001), and 100% to 37.8% (P < 0.001), respectively. The improvements in the cardiac disorders were maintained up to 5 years except for E/e′. In patients with LVEF < 40%, significant delayed improvement of LVEF beyond 1 year was observed (ΔLVEF = 10.5 ± 18.5, P = 0.001), but not in patients with LVEF of 40–49%. The cumulative incidence of HF hospitalization was 12.6% at 5 years. Baseline diastolic dysfunction was the only independent predictor for subsequent HF hospitalization. Conclusions In patients undergoing AF ablation with coexisting HF, all cardiac disorders significantly improved after the procedure, which was mostly maintained during 5 year follow‐up. |
topic |
Atrial fibrillation Catheter ablation Heart failure Systolic dysfunction Diastolic dysfunction |
url |
https://doi.org/10.1002/ehf2.13160 |
work_keys_str_mv |
AT tetsumakawaji impactofcatheterablationforatrialfibrillationoncardiacdisordersinpatientswithcoexistingheartfailure AT satoshishizuta impactofcatheterablationforatrialfibrillationoncardiacdisordersinpatientswithcoexistingheartfailure AT takanoriaizawa impactofcatheterablationforatrialfibrillationoncardiacdisordersinpatientswithcoexistingheartfailure AT shintaroyamagami impactofcatheterablationforatrialfibrillationoncardiacdisordersinpatientswithcoexistingheartfailure AT masashikato impactofcatheterablationforatrialfibrillationoncardiacdisordersinpatientswithcoexistingheartfailure AT takafumiyokomatsu impactofcatheterablationforatrialfibrillationoncardiacdisordersinpatientswithcoexistingheartfailure AT shinjimiki impactofcatheterablationforatrialfibrillationoncardiacdisordersinpatientswithcoexistingheartfailure AT kohono impactofcatheterablationforatrialfibrillationoncardiacdisordersinpatientswithcoexistingheartfailure AT takeshikimura impactofcatheterablationforatrialfibrillationoncardiacdisordersinpatientswithcoexistingheartfailure |
_version_ |
1724178606404403200 |